The one conceptual key to improving newborn healthcare outcomes is thought to be bridging the access gap to care, particularly in sub-Saharan Africa. However, recent studies have reported conflicting results relative to establishing a link between outcomes and access to care intervention programs.

Defined as a serum sodium (Na⁺) concentration below 135 mmol/L, hyponatremia is likely the most prevalent and clinically significant electrolyte abnormality in medical practice, most recently associated with an adverse COVID-19 outcome. A working knowledge of how this disorder presents in mental health practice is advantageous for psychiatrists. Most often arising as an adverse reaction to psychopharmacological agents including antidepressants and mood stabilizers, hyponatremia usually develops slowly, leading to subtle symptoms such as lethargy and confusion.

The use of administrative databases to determine predictors for heart failure (HF) readmission, cardiovascular, or all-cause mortality (ACM) requires HF coding that is verifiable. It is assumed that administrative databases have HF verified via coders based on physician documentation and additional criteria.

Background: In a recent study, it was shown that patients with pT1 adenocarcinoma of the esophagus or stomach have a shorter survival time compared to an age- and gender-matched group from the normal population despite curative therapy. The reasons for the loss of expected life years (YLL) can only be discussed. The aim of the present evaluation is to analyze the influence of the patients' gender on the results.

The number of individuals with all-stage chronic kidney disease (CKD) reached almost 700 million in 2017, which is more people than those with diabetes, osteoarthritis, chronic obstructive pulmonary disease (COPD), asthma, or depressive disorders [1]. A multitude of studies have been published in the field of CKD based on patho-physiological considerations, screening, etiological factors, clinical observations, targeted therapeutic interventions, but very little is known about the fate of a patient, who has CKD  and who is followed for years by his treating physician and the reference nephrologist.